Pharmacology Core to speed safer, smarter drug dosing for infectious diseases
Official title: Pharmacology Core
Funded at Rhode Island Hospital · NIH-11394308 · Data updated 2026-11-12
A Pharmacology Core at Rhode Island Hospital will help turn early drug ideas into safer, more effective dosing for infectious diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | August 16, 2025 |
| Project end | July 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $325,688 |
| NIH project number | 5P20GM156688-02 |
| Project ID | NIH-11394308 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with infectious diseases could indirectly benefit as new drug candidates advance through development and dosing optimization.
✕Less likely to help
Healthy volunteers or non-infectious disease areas may not directly benefit from this core.
What this research studies
This program provides PK analysis, in vitro assays, and advanced analytics to support projects in the COBRE Translational Approaches for Pathogens of Human Significance. It will analyze how drugs are absorbed, distributed, metabolized, and eliminated to inform dosing strategies. The core collaborates with researchers to generate data that move drug candidates toward smarter, individualized dosing for patients.
Why it matters
Potential benefit: If successful, patients could receive more effective doses with fewer side effects for infectious diseases.
How similar studies have gone: PK core facilities have previously accelerated drug development by providing specialized analyses and assays.
Where this research is happening
-
Rhode Island Hospital
Providence, United States Active
Researchers
- Principal investigator: Slitt, Angela L — Rhode Island Hospital
- Study coordinator: Slitt, Angela L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.